Activation of the AP-1 complex of transcription factors is one of the earliest nuclear responses to mitogenic stimuli. We demonstrate directly that AP-1 activity is required for human cells to proliferate in response to serum. We also find that activity of the AP-1 complex is selectively reduced in old human fibroblasts prior to their entering a fully senescent state. Levels of Fos protein induced through diverse signal transduction pathways, the amount of AP-1 DNA binding activity in vitro, and the activity of an AP-1-dependent reporter gene in vivo are substantially decreased as fibroblasts age. Moreover, the composition of the AP-1 complex changes, so that old cells produce predominantly Jun-Jun homodimers instead ofFos-Jun heterodimers. Changes in AP-1 activity may be due in part to changes in posttranslational modification of Fos protein that impair its ability to form active DNA-binding heterodimers with Jun These data suggest that changes in AP-1 activity may contribute to the inability of senescent cells to proliferate in response to mitogens.
Human diploid fibroblasts (HDFs) undergo a finite number of population doublings in vitro (1) , which is inversely proportional to the age of the donor. This observation and the direct correlation seen between the maximum life span of animal species and the replicative life span of their fibroblasts cultured in vitro (2) suggest that mechanisms underlying HDF senescence in vitro may play a role in the decline of many functions seen during aging in vivo (for a review, see ref. 3) . Senescent HDFs are unable to proliferate in response to normally mitogenic extracellular stimuli and appear to be blocked within the G1 phase of the cell cycle (4, 5) . Because growth factor receptors generally appear to be functional in senescent HDFs (6) , the block to proliferation apparently lies between the stimulation of membrane receptors and the initiation of S phase.
Expression of several cellular genes including c-fos (7-9), c-Ha-ras (10) , and c-myc (11, 12) is required for cells to progress through the G1 phase of the cell cycle and enter into DNA synthesis. But expression of these and other cell-cycleregulated genes is not appreciably reduced in senescent cells (13) , with one reported exception, that of c-fos (14) . c-fos is a particularly attractive candidate as a control point for cell proliferation since it encodes a transcription factor with the potential to regulate events later in progression through GU. Fos is a member of a family of transcription factors that contain highly conserved positively charged DNA-binding domains and leucine-zipper motifs. Fos proteins act in heterodimeric complexes with members of the Jun family of protooncogenes by binding to specific regulatory elements termed AP-1 sites (for review, see ref. 15 ). We show here that AP-1-binding factors constitute a control point for G1 progression by selectively inactivating AP-1-binding factors in living cells. Moreover, we show that as cells begin to age they show a striking decline in AP-1 activity. We suggest that AP-1 activity may be one of the major molecular defects responsible for the decline in the proliferative response to mitogens seen during cellular senescence.
MATERIALS AND METHODS
Cell Culture and Emulsion Autoradiography. Human Hs68 fibroblasts (American Type Culture Collection CRL 1635) were grown in Dulbecco's modified Eagle's medium (DMEM) supplemented with 1 mM glutamine and 10% (vol/ vol) fetal bovine serum (FBS). Young, old, and senescent fibroblasts were tested in parallel with other experiments for their ability to synthesize DNA by emulsion autoradiography using Kodak nuclear track emulsion as described (9) .
Microinjection and Immunocytochemistry. Microinjection and visualization of cells was as described (9) . Synthetic double-stranded oligodeoxynucleotides used in all assays contained a single copy of a wild-type AP-1 site (5'-TCGACGGTATCGATAAGCTATGACTCATCCGGGG-GATC-3') or a mutant site (5'-TCGACGGTATCGATAAGC-TATAAGTTATCCGGGGGATC-3'). Oligonucleotides were injected at 0.3 mg/ml with nonspecific rabbit IgG at 0.5 mg/ml. Fixation and staining with rabbit anti-Fos and antif3-galactosidase was as described (9) . Micrographs in Figs. 3 and 4 were taken using identical exposure and printing conditions to allow direct comparison. DNA Affinity Precipitation Assays. Radiolabeled cells were harvested in phosphate-buffered saline (PBS) containing 0.1% Nonidet P-40 (1 ml per 10-cm plate). Nuclei were pelleted 15 sec at 40C at 12,000 x g, and buffer was aspirated. Proteins were extracted in 4 vol of high-salt buffer (20 mM Hepes, pH 7.9/400 mM KCl/10 mM NaF/0.5 mM MgSO4/1 mM EDTA/1 mM dithiothreitol/1 mM aprotinin/1 mM leupeptin/1 mM pepstatin) for 30 min on ice. Nuclei were pelleted 10 min at 4°C as above; the supernatants were recovered, and DNA affinity precipitation assays were performed as described (16) (18, 19) . Thus, microinjection of oligonucleotides containing a consensus AP-1 binding site should effectively compete for proteins required for transcriptional activation of genes containing these sites, neutralizing cellular AP-1 activity. To test whether AP-1 activity was required to traverse G1, AP-1 oligonucleotides (0.3 mg/ml) and nonspecific rabbit IgG (0.5 mg/ml) were mixed and microinjected into quiescent serum-deprived young HDFs. Cells were refed with medium containing 10%o FBS and [3H]thymidine (2 ttCi/ml). Thirty-six hours after refeeding, cells were fixed, stained for IgG to identify injected cells (9, 20) , and coated with nuclear track emulsion to identify cells that had initiated DNA synthesis. Injection of nonspecific antibodies has no detectable effects on DNA synthesis (20) old cells. Because the DNA affinity precipitation assays are performed at high oligonucleotide concentration, this assay detects relatively low-affinity protein-DNA interactions and, therefore, probably underestimates the reduction in effective AP-1 binding activity in the old cells. Consistent with this conclusion, we observe an =10-fold reduction in serumstimulated AP-1 activity as measured in mobility-shift assays (data not shown).
AP-1 Transcriptional Activity in Intact Cells Decreases During Aging. The reduction in AP-1 DNA-binding activity that accompanies cellular aging suggests that transcription of AP-1-dependent genes is reduced in old cells. To test this hypothesis, we microinjected individual young (MPD = 46) and old (MPD = 76) cells with a lacZ reporter gene (0.5 mg/ml) under the control of four tandem AP-1 sites. Six hours after injection, cells were refed with medium containing or lacking phorbol 12-myristate 13-acetate (PMA; 100 ng/ml), incubated for 2 hr, and fixed for indirect immunofluorescence staining. As shown in Fig. 3 (Fig. 4 A and B) . After stimulation, Fos protein rose to much higher levels in young compared to old fibroblasts (compare Fig. 4 C and D) . Similar results were seen in two other human fibroblast lines, HF and A2 (data not shown). Thus, the amount of protein reactive with our Fos antiserum is reduced in old cells.
To corroborate this observation, we performed immunoprecipitation analysis using young, old, and senescent cells (Table 1) . Serum-deprived fibroblasts were stimulated with various agents in the presence of [35S]methionine and harvested 90 min later for immunoprecipitation analysis. Fig. 5 shows that young cells expressed much higher levels of Fos than old or senescent fibroblasts in response to cAMP, PMA, serum, or platelet-derived growth factor. Fos induction was impaired in old cells in response to all of the stimuli tested, even though they act through several different cis-acting elements in the c-fos promoter. Furthermore, these results also indicate that Fos synthesis was decreased to similar extents in old and senescent cells, despite a 4-to 5-fold higher proliferation rate in the former cultures. Thus, Fos synthesis levels fall as proliferation potential declines, not after entry into a fully senescent state.
We next did a time-course experiment to measure the levels of Fos and Jun expression in serum-stimulated cells and the extent to which the proteins formed heterodimers.
[35S]Methionine was added at various times after stimulation, 1 hr prior to harvesting. Lysates were prepared under nondenaturing conditions and diluted to contain equal amounts of incorporated 35S. Half tated with Fos antibodies (Fig. 6A) and half was immunoprecipitated with Jun antibodies (Fig. 6B) . Old fibroblasts synthesized much lower amounts of Fos protein than young fibroblasts when quiescent (Fig. 6A, lanes 1 and 2) or during the first (lanes 3 and 4) or second (lanes 5 and 6) hour of serum stimulation. In young cells, a fraction of the newly synthesized Fos protein was recovered in complexes with Jun protein within 1 hr of stimulation (Fig. 6B, lane 3 (Fig. 6B, lane 4) . This is largely due to reduction in total Fos protein concentration in the old cells. But, although some Fos protein is synthesized by these cells (Fig. 6A, lane 4) , we observe none either in complex with Jun (Fig. 6B, lane 4) or in active AP-1-binding complexes (Fig. 2) . Therefore, we suggest that the Fos protein synthesized in old cells may be impaired in its ability to form active heterodimeric DNA-binding complexes with Jun. Fos Protein Is Modified Differently in Young and Old Fibroblasts. To test the hypothesis that the Fos protein synthesized in old cells differs from that produced by young cells, we analyzed immunoprecipitated Fos by highresolution two-dimensional gel electrophoresis. Fig. 7 shows that Fos was resolved into at least seven isoforms in young cells stimulated with serum or cAMP. In old cells only some ofthe isoforms were seen, with those labeled 1-4 being barely detectable or completely absent. Old serum-stimulated cells contained two other isoforms (labeled 8 and 9) at more acidic isoelectric points, and old cAMP-stimulated cells showed only one major isoform (labeled 5) and barely detectable amounts of isoforms labeled 1 and 4. Thus, in addition to expressing lower amounts of Fos in response to stimulation, the Fos protein expressed by old fibroblasts is modified to produce a smaller number of more acidic (and presumably more highly phosphorylated) isoforms. These modified forms of Fos may differ in their ability to form heterodimers with Jun or to bind DNA.
DISCUSSION
This study shows that AP-1 activity is required in primary human fibroblasts for the initiation of DNA synthesis in response to serum. Since Fos is a major constituent of the proteins that bind specifically to the oligonucleotide microinjected (Fig. 2) , the previously described requirement for Fos during mitogen-induced growth (7) (8) (9) products were resolved on high-resolution two-dimensional gels as described (17) . All immunoprecipitations contained equal amounts of
[35S]methionine. Total immunoprecipitation products were electrophoresed on high-resolution two-dimensional gels except for young cells stimulated with serum in which only 25% of the immunoprecipitation product was electrophoresed to allow resolution of Fos isoforms. Left to right corresponds to acidic to basic and top to bottom corresponds to lower to higher electrophoretic mobility in the denaturing second dimension. Isoforms are labeled 1-9. I Proc. Natl. Acad. Sci. USA 89 (1992) pation of Fos in a DNA-bound transcription complex. We also determined that AP-1 activity was decreased significantly in old and senescent fibroblasts. This observation contrasts with generally modest (up to 2-fold) differences seen in other cellular properties during aging, including amounts of Oct-1 binding activity (data not shown), levels of DNA methylation (21) , translocation of protein kinase C (31), size and number of extrachromosomal DNA elements (23) , length of telomere sequences (24) , rate of DNA replication (25) , and the expression of 11 growth-related genes excluding c-fos (13) .
Old cells that displayed decreased AP-1 activity in vitro and in vivo were not fully senescent. They were still capable ofa limited number ofcell divisions, but at a severely reduced growth rate reflected by a 3.5-fold decrease in the number of cells incorporating [3H]thymidine over a 36-hr period ( Table  1 ). The fact that AP-1 activity decreased during the onset of proliferative decline in these cells, rather than when cells became fully senescent, suggests a critical connection between decreased AP-1 activity and the ability offibroblasts to proliferate in culture.
Decreased AP-1 activity could be due to reduced expression of components of the AP-1 complex or to production of dominant inhibitors that block the DNA-binding or transcriptional activity of the complex. Our data are most consistent with reduced synthesis coupled with altered posttranslational processing of the Fos protein. Reduced synthesis of Fos protein is likely due to a reduction in c-fos gene transcription as reported for another primary human cell line (14) . Although our data do not directly address the mechanism of this reduction, reduced Fos protein synthesis in response to several stimuli that act through diverse regulatory elements in the c-fos promoter (15) suggests that a generalized repression of c-fos transcription, perhaps due to expression of a dominant inhibitor, rather than selective loss of inducing signals, is responsible for reduced Fos synthesis. This model is consistent with observations suggesting dominance of the senescent phenotype (22, 26) .
One such inhibitor might be the product of the retinoblastoma (Rb) gene. Rb, which is a growth suppressor gene (27) , inhibits the expression of reporter genes driven by a c-fos promoter (28) and is not phosphorylated in senescent IMR-90 fibroblasts in response to serum addition (29) . In contrast, we did not see changes in the expression or phosphorylation state of Rb or p53 immunoprecipitated from young and old Hs68 fibroblasts, even though these cells showed large differences in their ability to express Fos. However, in subsequent experiments we have seen decreased phosphorylation of Rb in fully senescent Hs68 cells (data not shown) as reported for IMR-90 fibroblasts, but only several MPDs later than initial decreases in Fos expression. Since phosphorylation ofRb begins at the onset ofDNA synthesis, well after the early to mid-G1 requirement for Fos for entry into S phase (9) , decreased phosphorylation of Rb may be secondary to loss of AP-1 activity and subsequent inability of cells to traverse G1.
In addition to the decrease in overall AP-1 activity, the selective reduction in Fos synthesis means that there is a significant change in the composition of residual AP-1 complexes in aging and senescent cells. This change in composition is potentially very important in the light of recent reports that AP-1 proteins interact with other transcription factors and that Fos-Jun heterodimers can differ in activity from Jun-Jun homodimers (30) .
These data provide a clear example of a change in a specific transcriptional activity during in vitro aging in fibroblasts. They also suggest, but do not prove, that changes in AP-1 activity might be responsible for the inability of normal diploid fibroblasts to replicate indefinitely. One way to address this question would be to establish cell lines that express higher levels of Fos in a regulated manner and then determine if these lines would proliferate longer than naive parental lines. However, since AP-1 activity is due to the protein products of at least two gene families, and our data indicate that Fos is posttranslationally modified to different extents during in vitro aging, evaluation of such experiments may not be straightforward. An approach that may prove more productive is to identify more of the regulatory proteins that control Fos expression.
